ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,727,000 | +15.9% | 2,372,497 | +0.9% | 0.06% | +18.9% |
| Q4 2021 | $8,392,000 | +13.1% | 2,350,631 | +15.3% | 0.05% | +6.0% |
| Q3 2021 | $7,422,000 | -18.4% | 2,039,067 | -2.3% | 0.05% | -16.7% |
| Q2 2021 | $9,095,000 | +20.7% | 2,086,036 | +13.8% | 0.06% | +17.6% |
| Q1 2021 | $7,535,000 | -9.1% | 1,833,362 | -11.7% | 0.05% | -15.0% |
| Q4 2020 | $8,289,000 | +26.2% | 2,077,420 | -14.6% | 0.06% | +7.1% |
| Q3 2020 | $6,566,000 | +20.6% | 2,431,777 | +22.8% | 0.06% | +16.7% |
| Q2 2020 | $5,444,000 | +41.6% | 1,979,623 | +21.5% | 0.05% | +17.1% |
| Q1 2020 | $3,844,000 | -50.0% | 1,628,766 | -0.4% | 0.04% | -31.7% |
| Q4 2019 | $7,683,000 | +13.4% | 1,634,729 | -19.3% | 0.06% | +7.1% |
| Q3 2019 | $6,773,000 | – | 2,024,806 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |